SNOMED CT-concept
|
waarneembare entiteit (waarneembare entiteit)
waarneembare entiteit
Observable entity
Id
363787002
Status
Primitive
Global Patient Set
|
aankleuringspatroon van 'mass enhancement' in laesie mamma met magnetic resonance imaging
aankleuringspatroon van 'non-mass enhancement' in laesie van mamma met magnetic resonance imaging
aantal intralobulaire nefrogene resten in preparaat van weefsel verkregen door excisie
aantal perilobulaire nefrogene resten in preparaat van weefsel verkregen door excisie
aanwezigheid van nefrogene resten in preparaat van weefsel verkregen door excisie
aanwezigheid van trombus in vena renalis
Age AND/OR growth period
16
Alanine transaminase in serum
algemene klinische toestand
38
anatomische locatie mucus
Antimicrobial susceptibility of organism by matrix assisted laser desorption ionization time of flight mass spectrometry
Assessment score
158
Benzodiazepine in urine by confirmatory technique
bepaling van antilichamen tegen SARS-CoV-2
bepaling van SARS-CoV-2-antigeen
1
bevinding van anamnese en/of onderzoek
154
Clinical performance measure
3
Concentration of 1,5-anhydroglucitol
Concentration of neurotransmitter in blood
Cycle threshold for nucleic acid detection in specimen using real-time polymerase chain reaction
detectie van SARS-CoV-2
2
Detection and differentiation of antibody to human immunodeficiency virus type 1 and human immunodeficiency virus type 2 by immunoassay
Detection of antibody to infective organism
6
Detection of Legionella pneumophila antigen in urine
Detection of Neisseria gonorrhoeae nucleic acid by amplified probe technique
Detection of opiate by screening method
Detection of Streptococcus pneumoniae antigen in urine
Differential count of white blood cells by automated method
Differential count of white blood cells by manual method
Direct antiglobulin test of cord blood
Disease activity score using 28 joint count
1
Environment observable
10
faciliteiten benodigd bij consult
Feature of entity
12
geschiktheid om deel te nemen aan klinische studie
Giardia lamblia antigen by enzyme immunoassay
Glucose in blood one hour after glucose dose in pregnancy
Glucose in blood one hour postprandial
Hematology observable
5
Histologic grade of dysplasia at proximal surgical margin
histologische type van eenduidig benigne laesie
histologische type van niet eenduidig benigne laesie
Identification code
6
Identification of bacteria by matrix assisted laser desorption ionization time of flight mass spectrometry
Identification of bacteria in sputum by culture
Identification of fungus by matrix assisted laser desorption ionization time of flight mass spectrometry
Identification of organism in smear by Gram stain
1
Identification of organism in wet smear by potassium hydroxide preparation
Identification of ova and parasites in fecal smear by concentration and trichrome stain
Imaging observable
25
Immunoglobulin G antibody to cyclic citrullinated peptide
in aanmerking komende klinische studies
Indocyanine green clearance rate
Interferon gamma in blood by Mycobacterium tuberculosis antigen stimulation
interpretatie van bevindingen
24
kwalitatieve distributie van nefrogene resten in preparaat van weefsel verkregen door excisie
Laboratory biosafety level
Lactate in blood
2
Length of cross section of myometrium in uterus specimen
Low density lipoprotein cholesterol by direct assay
Major crossmatch compatibility by immediate spin technique
mate van blootstelling aan daglicht
Measurement of heme oxygenase-1
Molecular, genetic AND/OR cellular observable
4
Monitoring features
4
Number of occurrences observable
4
observatie betreffende behandeling met geneesmiddel
24
observatie betreffende functioneren
118
observatie betreffende lichaamsvloeistof
9
observatie betreffende lymfeklier
21
observatie betreffende sociale en persoonlijke voorgeschiedenis
24
Observation using immunohistochemistry
37
Opiate in urine by confirmatory technique
Parameter
3
Population statistic
4
Prescription observable
6
Presence of Helicobacter pylori in stool
1
Presence of macroscopic perforation of cecum and/or colon and/or rectum
Presence of macroscopic perforation of small intestine by primary malignant neoplasm of small intestine
Presence of microcalcification in excised breast specimen
Presence of necrosis in excised breast specimen
Presence of Streptococcus agalactiae in genital system by organism specific culture
Presence of white blood cells in stool
Process
6
Proliferative mass observable
4
Radiation therapy observable
1
reden voor afwijken van richtlijnen
Rhesus antibody observable
Rheumatoid factor in serum
Risk level
7
Rubella virus antibody by screening latex agglutination
Smooth muscle actin immunoglobulin G antibody
Specimen observable
59
Status of intactness of mesorectal specimen
1
Status of intactness of renal capsule in excised kidney specimen
status van patiëntcontact in multidisciplinair overleg
Substance observable
7
Surgical margin observable
22
Temporal observable
72
Thiamine in whole blood
Treponema pallidum antibody by screening enzyme immunoassay
trigger
type consult
type gedrag en/of manier van communiceren bij benaderen van zorgafnemer
urgentie
Viral load
zorgfase
zorgvormtype van onvrijwillige zorg
